Get started
Bone Biologics CorpBone Biologics CorpBone Biologics Corp

Bone Biologics Corp

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BBLG chart


Full chart

BBLG upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.85 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.78 USD
Net income (FY)
‪−8.95 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪521.82 K‬
Beta (1Y)
−0.24

Employees


Employees (FY)
2
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−4.47 M‬ USD

About Bone Biologics Corp


Sector
Health Technology
Industry
Medical Specialties
CEO
Jeffrey Frelick
Website
bonebiologics.com
Headquarters
Burlington
Founded
2004
FIGI
BBG007GF2K51
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BBLG news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BBLG is 1.36 USD — it has increased by 4.62% in the past 24 hours. Watch Bone Biologics Corp stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bone Biologics Corp stocks are traded under the ticker BBLG.
BBLG stock hasn't changed in a week, the month change is a −23.60% fall, over the last year Bone Biologics Corp has showed a −66.27% decrease.
We've gathered analysts' opinions on Bone Biologics Corp future price: according to them, BBLG price has a max estimate of 16.75 USD and a min estimate of 16.75 USD. Watch BBLG chart and read a more detailed Bone Biologics Corp stock forecast: see what analysts think of Bone Biologics Corp and suggest that you do with its stocks.
BBLG reached its all-time high on Aug 10, 2017 with the price of 35,400.00 USD, and its all-time low was 0.80 USD and was reached on Sep 13, 2024. View more price dynamics on BBLG chart.
See other stocks reaching their highest and lowest prices.
BBLG stock is 6.15% volatile and has beta coefficient of −0.24. Track Bone Biologics Corp stock price on the chart and check out the list of the most volatile stocks — is Bone Biologics Corp there?
Today Bone Biologics Corp has the market capitalization of ‪726.56 K‬, it has decreased by −21.51% over the last week.
Yes, you can track Bone Biologics Corp financials in yearly and quarterly reports right on TradingView.
Bone Biologics Corp is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
BBLG earnings for the last quarter are −0.67 USD per share, whereas the estimation was −0.67 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.60 USD per share. See more details about Bone Biologics Corp earnings.
Bone Biologics Corp revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BBLG net income for the last quarter is ‪−783.73 K‬ USD, while the quarter before that showed ‪−865.97 K‬ USD of net income which accounts for 9.50% change. Track more Bone Biologics Corp financial stats to get the full picture.
No, BBLG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 2.00 employees. See our rating of the largest employees — is Bone Biologics Corp on this list?
Like other stocks, BBLG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bone Biologics Corp stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bone Biologics Corp technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bone Biologics Corp stock shows the sell signal. See more of Bone Biologics Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.